Home
Conditions
Primary Myelofibrosis

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

453 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Completed

3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

NCT00381550

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blast Crisis, +37 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

NCT00351975

Conditions: Accelerated Phase of Disease, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, +47 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

Princess Margaret Hospital Cashmere, Canterbury, New Zealand

View Trial Details

Completed

A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM)

NCT00287261

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations: Cancer Care Services Brisbane, Queensland, Australia

University Hospital Leuven Leuven, Belgium

Hopital Avicenne and Paris 13 University Bobigny, France

Medizinische Klinik Kiel Kiel, Germany

View Trial Details

Completed

INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

NCT01164163

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +37 more
Locations: UAB Comprehensive Cancer Center Birmingham, Alabama, United States

Children's Hospital of Orange County Orange, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Children's Hospital Colorado Center for Cancer and Blood Disorders Aurora, Colorado, United States

View all 24 locations

View Trial Details

Completed

Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders

NCT00437086

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloproliferative Disorders, +13 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States

View Trial Details

Completed

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

NCT00004258

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +83 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

NCT00589563

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +70 more
Locations: Banner Good Samaritan Medical Center Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +116 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

NCT00445731

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +96 more
Locations: Not specified

View Trial Details

Completed

Lenalidomide and Prednisone in Treating Patients With Myelofibrosis

NCT00227591

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations: Eastern Cooperative Oncology Group Boston, Massachusetts, United States

View Trial Details

Primary Myelofibrosis

Primary Myelofibrosis trial results

Related conditions